Today, most financing reforms focus on establishing reimbursement methods that help achieve cost containment and efficiency without compromising healthcare quality, as Guinness et al. (2022) reported. These reforms trigger the debate concerning who should oversee the process of setting reimbursement rates between providers and payers. Each party has vested interests that may conflict, affecting their relationships. Although both parties are instrumental in the healthcare sector, this paper defends the position that payers should oversee the setting of reimbursement rates.
Quality Improvement
Allowing payers to oversee the process of setting reimbursement rates incentivizes providers to deliver better and high-quality care, improving patient outcomes and creating an efficient healthcare sector. Payers are interested in linking quality metrics to performance standards, as reflected by calls for value-based reimbursement schemes. With the healthcare system’s evolution, payers call upon providers to shift their focus to value services (Axene, 2023). Payers perceive value as the intersection between quality and cost. The significant effect of value-based reimbursement (VBR) is that it inspires healthcare professionals to provide the optimal services at the lowest cost. This model rewards providers for exceeding performance standards and sometimes punishes them for failing to meet the goals (Axene, 2023). Hence, payers ensure reimbursement rates align with care quality.
Quality Work
Unlimited Revisions
Affordable Pricing
24/7 Support
Fast Delivery